A detailed history of Fi3 Financial Advisors, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Fi3 Financial Advisors, LLC holds 26,000 shares of VXRT stock, worth $16,120. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,000
Previous 26,000 -0.0%
Holding current value
$16,120
Previous $17,000 29.41%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$0.6 - $1.41 $3,600 - $8,460
6,000 Added 30.0%
26,000 $18,000
Q1 2023

May 04, 2023

BUY
$0.71 - $1.25 $1,065 - $1,875
1,500 Added 8.11%
20,000 $15,000
Q4 2022

Feb 06, 2023

BUY
$0.75 - $2.24 $4,875 - $14,560
6,500 Added 54.17%
18,500 $17,000
Q4 2021

Jan 27, 2022

BUY
$5.77 - $7.96 $69,240 - $95,520
12,000 New
12,000 $75,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $78.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Fi3 Financial Advisors, LLC Portfolio

Follow Fi3 Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fi3 Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fi3 Financial Advisors, LLC with notifications on news.